10.1016/j.drup.2026.101413 34
Our laboratory is the first to have observed RSL3-induced DNA damage and previously unreported suppression of DNA repair via limiting of pNPM1 levels
Writingoriginal draft: AA, KB, DQ, NA, GA
Common patterns from user reports include substantial appetite suppression within the first week or two of treatment, meaningful weight loss averaging around 10% of starting body weight by month three, the phenomenon users describe as a "whoosh" of accelerated weight loss after each dose escalation, and significant psychological relief from constant food-related thoughts
Do you have insulin resistance, prediabetes, fatty liver disease, or metabolic syndrome
Quick Answer: Generalized skin sensitivity is not a recognized adverse effect in FDA labeling for semaglutide, though injection site reactions occur in 1.4-2.4% of patients using subcutaneous formulations